Evidence map›Paper›PMID 30546315›Full record

ArticleFrontiers in physiology2018

Changes of Intracellular Porphyrin, Reactive Oxygen Species, and Fatty Acids Profiles During Inactivation of Methicillin-Resistant

Jiaxin Wu, Zhaojuan Chu, Zheng Ruan, Xiaoyuan Wang, Tianhong Dai, Xiaoqing Hu

Open access · goldAbstract read
In one paragraph

Article in Frontiers in physiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 1 synthesis or guideline pooled it, 70 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Life (Basel, Switzerland) · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. The impact of sublethal antimicrobial blue light on lipidomic changes ofFrontiers in cellular and infection microbiology · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Jiaxin WuState Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi, China.
Zhaojuan ChuState Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi, China.
Zheng RuanState Key Laboratory of Food Science and Technology, School of Food Science and Technology, Nanchang University, Nanchang, China.
Xiaoyuan WangState Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi, China.
Tianhong DaiDepartment of Dermatology, Harvard Medical School, Boston, MA, United States.
Xiaoqing HuState Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi, China.
Jiangnan University · CNHarvard University · USNanchang University · CNState Key Laboratory of Food Science and Technology · CN

Funding

Antimicrobial blue light inactivation of pathogenic microbesR01AI123312 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI DAI, TIANHONG · 2016 to 2020
$2.6M
NIAID NIH HHS R01 AI123312
6 · The paper itself

Abstract

Antimicrobial blue light (aBL) has attracted increasing interest for its antimicrobial properties. However, the underlying bactericidal mechanism has not yet been verified. One hypothesis is that aBL causes the excitation of intracellular chromophores; leading to the generation of reactive oxygen species (ROS) and the resultant oxidization of various biomolecules. Thus, monitoring the levels of redox-sensitive intracellular biomolecules such as coproporphyrins, as well as singlet oxygen and various ROS may help to uncover the physiological changes induced by aBL and aid in establishing the underlying mechanism of action. Furthermore, the identification of novel targets of ROS, such as fatty acids, is of potential significance from a therapeutic perspective. In this study, we sought to investigate the molecular impact of aBL treatment on methicillin-resistant

Indexed as

antimicrobial blue lightcoproporphyrinlipidsmembrane injuriesmethicillin-resistant Staphylococcus aureusunsaturated fatty acids

Identifiers

PMID30546315
PMCPMC6279940
OpenAlexW2902925983

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.